AuntMinnieEurope

Panel discussion at ISTAT26 conference in Vienna with speaker presenting on stage while seated panelists listen

EANM 2026: How early is early enough in prevention?

Experts question whether PET-based screening is ready for cancer, heart disease, and Alzheimer’s, and what evidence would justify it.

Featured

Clinical research presentation slide showing FAP RLT experience data table with patient outcomes across multiple institutions and speaker photo

EANM: Thomas Hope on what’s next in FAP-targeted theranostics

From theranostics to patient access: What to expect at EANM 2026

PET scan comparison showing SAFOV baseline and 1-minute and 5-minute time-point imaging with tracer uptake patterns

EANM: Next-generation PET scanner cuts imaging time to one minute

October 18, 2026

Medical CT scan visualization showing coronal, sagittal, and axial views with 3D organ segmentation including kidney, liver, aorta, and tumor models.

VR boosts accuracy, confidence for evaluating abdominal neuroblastoma

October 16, 2026

Professional man in dark suit at medical conference with Ultravist product display in background

René Chapot challenges measures of success in distal thrombectomy

October 16, 2026

Panel discussion with four business professionals seated on stage against red LED backdrop at conference event

At neuroRAD, three pioneers look beyond technical success

October 15, 2026

Check out our Cases of the Week!

0-day-old neonate with failure to thrive revisited

A 0-day-old neonate, born at 37 weeks and 6 days, with failure to thrive.

19-year-old man with lower abdominal pain revisited

60-year-old woman with multiple incidental peritoneal nodules

Panel discussion at ISTAT26 conference in Vienna with speaker presenting on stage while seated panelists listen

EANM 2026: How early is early enough in prevention?

EANM: Thomas Hope on what’s next in FAP-targeted theranostics

EANM: Next-generation PET scanner cuts imaging time to one minute

René Chapot challenges measures of success in distal thrombectomy

From theranostics to patient access: What to expect at EANM 2026

Professional man in navy blazer smiling at conference event wearing ID badge

neuroRAD video: Joe Lennerz on continuous evidence tracking in medical AI

JFR: How to integrate AI in emergency imaging

AI leads to lower turnaround times for high-volume imaging

ESHNR heads to Budapest with dental imaging, cancer updates and AI on the agenda

Video: Charles Kahn on keeping pace with radiology AI

A26 NMM World Leading Meeting event branding overlaid on aerial cityscape at sunset

EANM: Affibody presents data on HER2 radioligand therapy

EANM: Akiram presents first clinical data for CD44v6-targeted therapy

GE HealthCare expands ultrasound portfolio

Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal

IBA gets order for 12 cyclotrons for U.S. PET tracer network

EANM: Affibody presents data on HER2 radioligand therapy

By AuntMinnieEurope.com staff writers

The Stockholm, Sweden-based company is highlighting progress across its radiopharmaceutical pipeline.

October 19, 2026

A26 NMM World Leading Meeting event branding overlaid on aerial cityscape at sunset

EANM: Akiram presents first clinical data for CD44v6-targeted therapy

By AuntMinnieEurope.com staff writers

The first-in-human ongoing phase I trial is evaluating Lu-177 AKIR001 in patients with irresectable or metastatic CD44v6-positive solid tumors.

October 19, 2026

A26 NMM World Leading Meeting event branding overlaid on aerial cityscape at sunset

GE HealthCare expands ultrasound portfolio

By AuntMinnie.com staff writers

The new system is built on the company’s cSound Architecture with speckle reduction imaging.

October 19, 2026

GE Healthcare ultrasound system with display monitor showing cardiac imaging and control panel on mobile cart

Nuclidium, NorthStar sign Cu-67 supply and manufacturing deal

By AuntMinnie.com staff writers

Cu-67 is the therapeutic half of Nuclidium’s theranostic platform, which pairs it with copper-61 (Cu-61) for diagnostic imaging.

October 19, 2026

Hand holding glowing atom symbol with blue and gold light effects against blurred tech background

IBA gets order for 12 cyclotrons for U.S. PET tracer network

By AuntMinnie.com staff writers

A KIUBE 300 system typically costs between €2.5 million and €5 million.

October 16, 2026

Philips, UMCG launch EU-funded cardiovascular disease project

By AuntMinnieEurope.com staff writers

The five-year research project will examine strategies for detecting, monitoring, and treating cardiovascular disease.

October 15, 2026

Thirona gets CE Mark for AI mucus plug analysis software

By AuntMinnieEurope.com staff writers

LungQ MP quantifies airway-occluding mucus plugs on chest CT and is certified as a class IIb medical device.

October 15, 2026

Medical professional reviewing lung CT scan images on multiple monitors in diagnostic workstation

GEHC’s MINItrace Magni cyclotron gets CE Mark

By AuntMinnie.com staff writers

MINItrace Magni is designed for in-house production of F-18, carbon-11, oxygen-15, and nitrogen-13 for PET tracers.

October 15, 2026

Brainomix adds patient input to e-Lung lung CT study

By AuntMinnie.com staff writers

The work extends Brainomix’s research collaboration with Boehringer Ingelheim.

October 14, 2026

Anatomical illustration of human lungs with bronchial branches and pulmonary blood vessels highlighted in pink and yellow

Breast cancer imaging: Patients must remain at the center

By Claudia Tschabuschnig

Experts at a European Society of Radiology (ESR) event in Vienna emphasized that diagnostic precision alone is not enough when it comes to breast cancer.

October 14, 2026

Aston University gets funding for pediatric brain tumor MRI research

By AuntMinnieEurope.com staff writers

The funded research will examine the use of MRI to improve diagnosis and treatment of children with brain tumors.

October 13, 2026

Five people holding a large ceremonial check for £45,000 charity donation in front of Town Centre Village storefront

Lu-177 PNT2002 before SBRT extends disease control in prostate cancer

A group from the University of California, Los Angeles, updated an analysis of outcomes from the LUNAR trial by 10 months.

October 13, 2026

X-ray scan of pelvis with highlighted prostate gland in red for medical diagnosis